1: Bézard E, Muñoz A, Tronci E, Pioli EY, Li Q, Porras G, Björklund A, Carta M. Anti-dyskinetic effect of anpirtoline in animal models of L-DOPA-induced dyskinesia. Neurosci Res. 2013 Dec;77(4):242-6. doi: 10.1016/j.neures.2013.10.002. Epub 2013 Oct 14. PubMed PMID: 24135129.
2: Hummel T, Hummel C, Friedel I, Pauli E, Kobal G. A comparison of the antinociceptive effects of imipramine, tramadol and anpirtoline. Br J Clin Pharmacol. 1994 Apr;37(4):325-33. PubMed PMID: 8018453; PubMed Central PMCID: PMC1364732.
3: Watanabe A, Nakai A, Tohyama Y, Nguyen KQ, Diksic M. Effects of anpirtoline on regional serotonin synthesis in the rat brain: an autoradiographic study. Nucl Med Biol. 2006 Apr;33(3):325-32. Epub 2006 Mar 9. PubMed PMID: 16631081.
4: Metzenauer P, Barnes NM, Costall B, Gozlan H, Hamon M, Kelly ME, Murphy DA, Naylor RJ. Anxiolytic-like actions of anpirtoline in a mouse light-dark aversion paradigm. Neuroreport. 1992 Jun;3(6):527-9. PubMed PMID: 1356500.
5: Rilke O, Will K, Jähkel M, Oehler J. Behavioral and neurochemical effects of anpirtoline and citalopram in isolated and group housed mice. Prog Neuropsychopharmacol Biol Psychiatry. 2001 Jul;25(5):1125-44. PubMed PMID: 11444681.
6: Göthert M, Hamon M, Barann M, Bönisch H, Gozlan H, Laguzzi R, Metzenauer P, Nickel B, Szelenyi I. 5-HT3 receptor antagonism by anpirtoline, a mixed 5-HT1 receptor agonist/5-HT3 receptor antagonist. Br J Pharmacol. 1995 Jan;114(2):269-74. PubMed PMID: 7881726; PubMed Central PMCID: PMC1510248.
7: Rádl S, Hezký P, Proska J, Krejcí I. Analgetically active substances derived from structures of anpirtoline and epibatidine. Gen Physiol Biophys. 1998 Jun;17 Suppl 1:26-9. PubMed PMID: 9789748.
8: Chenu F, David DJ, Leroux-Nicollet I, Le Maître E, Gardier AM, Bourin M. Serotonin1B heteroreceptor activation induces an antidepressant-like effect in mice with an alteration of the serotonergic system. J Psychiatry Neurosci. 2008 Nov;33(6):541-50. PubMed PMID: 18982177; PubMed Central PMCID: PMC2575758.
9: Pérez Maceira JJ, Mancebo MJ, Aldegunde M. The involvement of 5-HT-like receptors in the regulation of food intake in rainbow trout (Oncorhynchus mykiss). Comp Biochem Physiol C Toxicol Pharmacol. 2014 Apr;161:1-6. doi: 10.1016/j.cbpc.2013.12.003. Epub 2013 Dec 21. PubMed PMID: 24365333.
10: Hillegaart V, Ahlenius S. Facilitation and inhibition of male rat ejaculatory behaviour by the respective 5-HT1A and 5-HT1B receptor agonists 8-OH-DPAT and anpirtoline, as evidenced by use of the corresponding new and selective receptor antagonists NAD-299 and NAS-181. Br J Pharmacol. 1998 Dec;125(8):1733-43. PubMed PMID: 9886765; PubMed Central PMCID: PMC1565750.
11: Schlicker E, Werner U, Hamon M, Gozlan H, Nickel B, Szelenyi I, Göthert M. Anpirtoline, a novel, highly potent 5-HT1B receptor agonist with antinociceptive/antidepressant-like actions in rodents. Br J Pharmacol. 1992 Mar;105(3):732-8. PubMed PMID: 1628159; PubMed Central PMCID: PMC1908466.
12: Rádl S, Kovárová L, Hezky P, Vosátka V, Königová O, Proska J, Krejcí I. Synthesis and analgesic activity of some condensed analogs of anpirtoline. Arch Pharm (Weinheim). 1999 Jun;332(6):208-12. PubMed PMID: 10399490.
13: Zhou W, Chen L, Paul J, Yang S, Li F, Sampson K, Woodgett JR, Beaulieu JM, Gamble KL, Li X. The effects of glycogen synthase kinase-3beta in serotonin neurons. PLoS One. 2012;7(8):e43262. doi: 10.1371/journal.pone.0043262. Epub 2012 Aug 17. PubMed PMID: 22912839; PubMed Central PMCID: PMC3422264.
14: Rádl S, Hezky P, Proska J, Krejcí I. Synthesis and analgesic activity of some quinazoline analogs of anpirtoline. Arch Pharm (Weinheim). 2000 Nov;333(11):381-6. PubMed PMID: 11129980.
15: Miczek KA, de Almeida RM. Oral drug self-administration in the home cage of mice: alcohol-heightened aggression and inhibition by the 5-HT1B agonist anpirtoline. Psychopharmacology (Berl). 2001 Oct;157(4):421-9. PubMed PMID: 11605102.
16: Engel J, Bork A, Nubert I, Schönenberger H. [Synthesis of 14C-anpirtoline]. Arch Pharm (Weinheim). 1988 Nov;321(11):821-2. German. PubMed PMID: 3219051.
17: Ahlander-Lüttgen M, Madjid N, Schött PA, Sandin J, Ogren SO. Analysis of the role of the 5-HT1B receptor in spatial and aversive learning in the rat. Neuropsychopharmacology. 2003 Sep;28(9):1642-55. Epub 2003 Jul 2. PubMed PMID: 12838273.
18: Rádl S, Hezky P, Proska J, Krejcí I. Synthesis and analgesic activity of some deaza derivatives of anpirtoline. Arch Pharm (Weinheim). 1999 Jan;332(1):13-8. PubMed PMID: 10073139.
19: O'Neill MF, Parameswaran T. RU24969-induced behavioural syndrome requires activation of both 5HT1A and 5HT1B receptors. Psychopharmacology (Berl). 1997 Aug;132(3):255-60. PubMed PMID: 9292625.
20: Rádl S, Hezky P, Proska J, Hejnová L, Krejcí I. Synthesis and analgesic activity of some side-chain modified anpirtoline derivatives. Arch Pharm (Weinheim). 2000 May;333(5):107-12. PubMed PMID: 10863793.